This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Bausch Health Americas, Inc., Louisiana State University and Agricultural & Mechanical College. Active years: 2023.
Company Filing History:
1 out of 1 
1 out of 838 Years Active: 2023
Title: Innovations in Ocular Drug Delivery by Yuri McKee
Introduction
Yuri McKee is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of ocular drug delivery, focusing on innovative methods to enhance the treatment of eye disorders. His work has the potential to improve the efficacy of pharmaceutical treatments for various ocular conditions.
Latest Patents
Yuri McKee holds a patent for an ocular drug delivery device. The patent describes a method of forming an ocular delivery device by exposing a solid, shaped cellulose polymer to a solution containing an active pharmaceutical ingredient (API) and a solvent capable of solubilizing the API. The polymer absorbs a portion of the solution, including the API and solvent. The method may also involve removing some of the absorbed solvent from the polymer through evaporation or drying. Various cellulose polymers, such as hydroxypropyl cellulose, can be utilized, and a range of APIs, including Cyclosporine, Tobramycin, and Vancomycin, can be incorporated. The ocular delivery devices created through this method are designed to treat a variety of eye disorders.
Career Highlights
Yuri McKee has worked with notable institutions, including Louisiana State University and Agricultural & Mechanical College and Bausch Health Americas, Inc. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.
Collaborations
Yuri has collaborated with professionals such as Kevin Halloran and Jean Jacob, enhancing his research and development efforts in ocular drug delivery.
Conclusion
Yuri McKee's innovative work in ocular drug delivery devices showcases his commitment to advancing medical technology. His patent and collaborations reflect his significant contributions to improving treatments for eye disorders.